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764a Wednesday, February 19, 2014hyperpolarization the channel modulation was arranged as follows: Kv7>>
TTX-sensitive VGSC=KATP>HCN>KNA>TTX-resistant VGSCRCav3;
while by the ability to induce depolarization the sequence was Kv7=4-AP-
sensitive Kv>>KNA>K2P>>Cav3>>KATP. The strongest and most
consistent effect on Em was achieved by manipulating the activity of M-chan-
nels. Thus, retigabine (M-channel enhancer) and XE991 (M-channel inhibitor)
hyperpolarized and depolarized neurons by approximately 10 mV each. Both
drugs had strong reciprocal effect on evoked action potential firing. Results ob-
tained in slices confirmed those obtained from culture. Acute topical applica-
tion of retigabine, ZD7288 (HCN blocker) and pinacidil (KATP channel
enhancer) to DRG in vivo significantly alleviated peripherally-induced pain
however, again, retigabine was the most efficacious.
Conclusions: Our study deciphers a toolkit of ion channels that sets Em of
nociceptive neuron somata and identifies M-channels as one of the main con-
trollers of nociceptor’s excitability.
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The pancreatic islets of Langerhans controls glucose homeostasis through the
regulated secretion of insulin. Gap junction channels coordinate membrane de-
polarization between b-cells in the islet, which coordinates oscillatory [Ca2þ]
at elevated glucose and suppresses spontaneous [Ca2þ] elevations under basal
glucose. b-cells are heterogeneous in their glucose-stimulated [Ca2þ] and the
balance between cellular excitability and coupling in determining the whole-
islet response is not well understood. Here we quantify how the electrical
response is shaped by the distribution of cellular excitability across the islet
and the strength of coupling between cells. We utilize mice that express muta-
tions to the KATP channel that decrease excitability in a population of b-cells,
which can be controlled through variable doses of tamoxifen induction of
CreER-recombinase, and quantified by GFP coexpression. To compare this
defined heterogeneity in cellular excitability with endogenous heterogeneity,
we also apply variable concentrations of the KATP-activator diazoxide to uni-
formly shift cellular excitability. In each case we compare experimental results
with predictions from a multicellular coupled oscillator model and a perco-
lating network model of the islet. Upon increased KATP mutant-channel
expression there is a sharp transition at ~15% expression between near-
normal [Ca2þ] and near-complete suppression of [Ca2þ]. Thus ~15% of inex-
citable cells can control islet electrical activity. This similarly impacts insulin
secretion and glucose homeostasis, such that mice transition from euglycemia
to diabetes. Similar results are obtained upon diaxoizde treatment indicating
this is a general behavior and not specifically dependent on mosaic mutant
KATP expression. These results could be described by both mathematical
models revealing the fundamental importance of heterogeneity and coupling
to islet physiology and glucose homeostasis. This will be important for under-
standing islet dysfunction caused by mutations that affect the electrical
response in diabetes.
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A challenge in ion channel drug discovery is the need to screen a large num-
ber of compounds and to measure the pharmacology of drug-ion channel
interaction. Automated patch clamp (APC) makes it possible to measure
the pharmacology of many compounds; however, the throughput required
for high throughput screening of compound libraries has been out of reach
of the first generation of APC instruments. Screening of large compound li-
braries has been done using indirect methodologies with higher false positive
and false negative errors. The Qube is a 384 channel, gigaohm-seal based
APC instrument for recordings from voltage-gated and ligand-gated ion
channels. It offers the capability to screen large compound libraries for ion
channel block or modulation. Data are obtained with a throughput of more
than 30,000 wells tested per 24 hours. In this study, we did high throughput,
voltage clamp recordings of Nav1.7, hERG and ASIC1A on the Qube.
Recordings were made on the QChip384 planar patch clamp consumable.
Here we demonstrate throughput of up to 1500 wells tested per hour with
a 95% success rate using multihole QChips. Using Nav1.7 and hERGexpressing cells we demonstrate that the recording are stable and have
good voltage control for at least 30 minutes. By repetitive alternating addi-
tions of high and low pH on the ASIC1A expressing cells, we demonstrate
the advantages of the liquid flow system in the QChip: the QChip384 has
flow channels and complete wash in/washout and indefinite waste. The capa-
bility of the Qube to handle 384 sites simultaneously combined with the
QChip384 architecture enable high throughput screening of compounds
with the highest output of true, direct electrophysiological recordings with
an uncompromised data quality.
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The U.S. Food and Drug Administration (FDA) guidelines S7B mandate the
measurement of inhibition of the human ether-a-go-go-related (hERG) ion
channel by new drug candidates as it has been found that drug inhibition of
the hERG channel can be associated with cardiac action potential (AP) prolon-
gation and lethal cardiac arrhythmias. However, hERG is only one of multiple
ion channels involved in forming the cardiac AP and therefore direct measure-
ment of the cardiac AP has the potential to detect the effects of the candidate
drug on multiple ion channels potentially affected. Stem cell-derived cardio-
myocytes (SC-CM) or induced pluripotent stem cells (iPS-CM) have many
of the phenotypic properties of authentic cardiomyocytes e.g. realistic ventric-
ular action potentials. In this work we show how the QPatch can trigger action
potentials using rapid switching from voltage to current clamp during record-
ings on the iPS-CM. We demonstrate that the current clamp recordings made
on this automated patch clamp device are comparable to results obtained on
standard manual patch clamp rigs. The integrated low volume glass flow chan-
nels of the QPatch minimize the consumption of iPS-CM cells - a valuable and
often limiting "consumable". Parallel recordings from up to 48 iPS-CM were
made on the QPatch HT with full analysis of action potential parameters
including action potential duration and upstroke velocity. We measured assay
success rates, the stability of action potentials and pharmacological profiles of
reference compounds. Current clamp measurements of these cardiomyocytes
offer important information to the understanding of the complex pharmacolog-
ical effect of compounds on ion channels involved in the AP. Our data pre-
sented here clearly demonstrate how automated patch clamp on QPatch can
augment the throughput of current clamp to meet new demands in drug
discovery.
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Residual force enhancement (RFE) is a characteristic of skeletal muscle
describing the increase in force exhibited following an active stretch on
the descending limb of the force-length relationship, compared to the force
of an isometric contraction at the final length. It has previously been argued
that RFE is a result of instable sarcomeres on the descending limb, causing
longer, weaker sarcomeres to lengthen to a greater extent than shorter, stron-
ger sarcomeres, when a myofibril is actively stretched. If this were the mech-
anism of RFE, then sarcomeres should become more non-uniform in length
after an active stretch. The purpose of this study was to investigate length
non-uniformities between sarcomeres within a myofibril in isometric contrac-
tions pre- and post-active stretch. We hypothesized that sarcomere lengths
would be less uniform in the post-stretch condition. Rabbit psoas muscle
myofibrils were stretched passively to an average sarcomere length of
3.2 mm. The myofibrils were then activated. Five seconds after full activa-
tion, myofibrils were rapidly shortened to an average sarcomere length of
2.4 mm, held at that length for ten seconds and then stretched back to
3.2 mm. Individual sarcomere lengths were then determined during the initial
isometric contraction and again following the active stretch. Standard devi-
ations of sarcomere lengths were compared to analyze non-uniformity.
Preliminary results gave normalized sarcomere length standard deviations
of 5.7 % and 10.2 % for the initial isometric contraction and following active
stretch respectively (103 % RFE). This supports the hypothesis that
